Harrow Health (HROW) Tops Q3 EPS by 9c

Harrow Health (NASDAQ: HROW) reported Q3 EPS of $0.33, $0.09 better than the analyst estimate of $0.24. Revenue for the quarter came in at $71.6 million versus the consensus estimate of $73.69 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Cummins wins battery storage contract for U.S. data center project
• Meta Platforms (META) call put ratio 1 call to 1.1 puts with a focus on August 19 weekly 682.50 calls